David A. Solomon

22.4k citations

212 papers · 12.1k indexed · 2 hit papers · h-index 56

Impact in

Psychiatry and Mental health top 0.1%
- Bipolar Disorder and Treatment
- Electroconvulsive Therapy Studies
- Schizophrenia research and treatment
Biological Psychiatry top 0.5%
- Tryptophan and brain disorders

Papers in

Genetics 51
- Glioma Diagnosis and Treatment 49
Psychiatry and Mental health 49
- Bipolar Disorder and Treatment 39
- Schizophrenia research and treatment 23
- Electroconvulsive Therapy Studies 18

Co-authors: Martin B. Keller Andrew C. Leon Jean Endicott Pamela J. Schettler Lewis L. Judd Hagop S. Akiskal Jack D. Maser William Coryell
Journals: Neuro-Oncology (12 papers)CHEST Journal (10 papers)American Journal of Psychiatry (9 papers)The Journal of Clinical Psychiatry (8 papers)Cancer Research (6 papers)
Partner nations: United States Germany United Kingdom

In The Last Decade

David A. Solomon

203 papers receiving 11.7k citations

Hit Papers

align trajectories log scale

A Prospective Investigation of the Natural History of the Long-term Weekly Symptomatic Status of Bipolar II Disorder 2003 · 923 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2003 Archives of General Psychiatry
2002 Archives of General Psychiatry

Peers

Countries citing papers authored by David A. Solomon

Since Specialization

Citations

This map shows the geographic impact of David A. Solomon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Solomon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Solomon more than expected).

Fields of papers citing papers by David A. Solomon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Solomon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Solomon. The network helps show where David A. Solomon may publish in the future.

Co-authorship network

The 25 scholars most cited alongside David A. Solomon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David A. Solomon Line = papers co-authored together David A. Solomon links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The Protective Role of Aqueous and Methanol Extracts of Aloe Vera on Ethanol-Induced Kidney and Brain Injury in Mice 落合康, A. L. Th. Moesveld, Lucy Swinton, J. Spiers, Aalaee Bazkiaei Pooya, Chris Blunsden, H. K. Adam, 健二郎梶谷, 王荣根, David A. Solomon, Hn 基因的一个隐性突变体, 赵翠红, Arthur T. Coumbe, Rosa Maria Tavares Fragoso, Vera Forer, K. Li, Bayu Kurniawan, Samaila Musa Chiroma	2025	0
2	cIMPACT-NOW update 9: Recommendations on utilization of genome-wide DNA methylation profiling for central nervous system tumor diagnostics Neuro-Oncology Advances ·Kenneth Aldape, David Capper, Andreas von Deimling, Caterina Giannini, Mark R. Gilbert, Cynthia Hawkins, Juergen Hench, Thomas S. Jacques, David Jones, David N. Louis, Sabine Mueller, Brent A. Orr, MacLean P. Nasrallah, Stefan M. Pfister, Felix Sahm, Matija Snuderl, David A. Solomon, Pascale Varlet, Pieter Wesseling	2025	9
3	Quantitative analysis of MGMT promoter methylation in glioblastoma suggests nonlinear prognostic effect Neuro-Oncology Advances ·David R. Gibson, Ahmed Ali Soliman Elsamahy, Eduardo A. Rodríguez, Susan M. Chang, 陈修会, Jennie Taylor, Jennifer Clarke, David A. Solomon, (unknown), John S. Witte, 横山剛, Hideho Okada, Mitchel S. Berger, Farid Chehab, Nicholas Butowski	2023	6
4	Whole tumor analysis reveals early origin of the TERT promoter mutation and intercellular heterogeneity in TERT expression Neuro-Oncology ·Christina Appin, Chibo Hong, Abigail K. Suwala, Stephanie Hilz, Radhika Mathur, David A. Solomon, Ivan Smirnov, Nicholas Stevers, Anny Shai, Albert Wang, Mitchel S. Berger, Susan M. Chang, Joanna J. Phillips, J Costello	2023	6
5	Conserved features of TERT promoter duplications reveal an activation mechanism that mimics hotspot mutations in cancer Nature Communications ·Carter J. Barger, Abigail K. Suwala, Katarzyna M. Soczek, Albert Wang, Ivan Matus T, Chibo Hong, Jennifer A. Doudna, Susan M. Chang, Joanna J. Phillips, David A. Solomon, J Costello	2022	13
6	Long-term follow-up of perianchor cyst formation after rotator cuff repair JSES International ·Frances McGrath, David A. Solomon, Pan Hong-qing, Hsin-Hui Huang, Jashvant Poeran, Haidong Xu, Amir Lebaschi, Aruna Seneviratne	2021	6
7	Preoperative MR Imaging to Differentiate Chordoid Meningiomas from Other Meningioma Histologic Subtypes American Journal of Neuroradiology ·Joe D. Baal, William Chen, David A. Solomon, Jonathan Pai, Sijia Tian, 澤田匡人, Nancy Ann Oberheim Bush, Michael W. McDermott, David R. Raleigh, Javier Villanueva-Meyer	2019	7
8	STAG2 Is a Biomarker for Prediction of Recurrence and Progression in Papillary Non–Muscle-Invasive Bladder Cancer Clinical Cancer Research ·王超, Frederik Prip, Brent T. Harris, David A. Solomon, Deborah L. Berry, Krysta Chaldekas, Anagha Kumar, Jeffry Simko, Jørgen Bjerggaard Jensen, Pritish K. Bhattacharyya, Ciaran Mannion, Jung-Sik Kim, George Philips, Lars Dyrskjøt, Todd Waldman	2018	24
9	Glioblastoma Cells Containing Mutations in the Cohesin Component STAG2 Are Sensitive to PARP Inhibition Molecular Cancer Therapeutics ·Melanie L. Bailey, Nigel J. O’Neil, Derek M. van Pel, David A. Solomon, Todd Waldman, Philip Hieter	2013	58
10	Targeted Therapy for BRAFV600E Malignant Astrocytoma Clinical Cancer Research ·Theodore Nicolaides, Huifang Li, David A. Solomon, Sujatmi Hariono, Rintaro Hashizume, Krister J. Barkovich, Stuart N. Baker, Barbara S. Paugh, Chris Jones, Tim Forshew, Guy Hindley, John Hodgson, Jung-Sik Kim, David H. Rowitch, William A. Weiss, Todd Waldman, C. David James	2011	113
11	Mutational Inactivation of STAG2 Causes Aneuploidy in Human Cancer Science ·David A. Solomon, Taeyeon Kim, Laura A. Díaz-Martínez, Julian J. Garcia, Abdel Elkahloun, Brent T. Harris, Jeffrey A. Toretsky, Steven A. Rosenberg, Neerav Shukla, Marc Ladanyi, Yardena Samuels, C. David James, Hongtao Yu, Jung-Sik Kim, Todd Waldman	2011	311
12	Pharmacologic Inhibition of Cyclin-Dependent Kinases 4 and 6 Arrests the Growth of Glioblastoma Multiforme Intracranial Xenografts Cancer Research ·Karine Michaud, David A. Solomon, Eric K. Oermann, Jung-Sik Kim, Bernd U. Schipper, Michael D. Prados, Tomoko Ozawa, C. David James, Todd Waldman	2010	254
13	Sample Type Bias in the Analysis of Cancer Genomes Cancer Research ·David A. Solomon, Jung-Sik Kim, Habtom W. Ressom, Zita A. Sibenaller, Timothy C. Ryken, Walter C. Jean, Darell D. Bigner, Hai Yan, Todd Waldman	2009	26
14	Manic/Hypomanic Symptom Burden and Cardiovascular Mortality in Bipolar Disorder Psychosomatic Medicine ·Jess G. Fiedorowicz, David A. Solomon, Jean Endicott, Andrew C. Leon, Chunshan Li, John P. Rice, William Coryell	2009	107
15	Identification of p18INK4c as a Tumor Suppressor Gene in Glioblastoma Multiforme Cancer Research ·David A. Solomon, Jung-Sik Kim, PI He-fang, Habtom W. Ressom, Michael C. Huang, Nicholas D. Coppa, J.W. Fück, Darell D. Bigner, Hai Yan, Walter C. Jean, Todd Waldman	2008	38
16	Mutational Inactivation of PTPRD in Glioblastoma Multiforme and Malignant Melanoma Cancer Research ·David A. Solomon, Jung-Sik Kim, Julia C. Cronin, Zita A. Sibenaller, Timothy C. Ryken, Steven A. Rosenberg, Habtom W. Ressom, Walter C. Jean, Darell D. Bigner, Hai Yan, Yardena Samuels, Todd Waldman	2008	102
17	Family functioning and mood disorders: A comparison between patients with major depressive disorder and bipolar I disorder. Journal of Consulting and Clinical Psychology ·Lauren M. Weinstock, Gabor I. Keitner, Christine E. Ryan, David A. Solomon, Ivan W. Miller	2006	55
18	Mixed venous oxygen tension and wedge pressure predicting survival in acute respiratory failure CHEST Journal ·N. Rad, David A. Solomon, Allan L. Goldman	1979	2
19	The Coca leaf and cocaine papers George E. Andrews, David A. Solomon	1975	22
20	HEADLIGHT GLARE AND MEDIAN WIDTH Highway Research Record ·Charles Magee Adams, David A. Solomon	1965	2

About David A. Solomon

David A. Solomon is a scholar working on Genetics, Psychiatry and Mental health, Neurology, Biological Psychiatry and Experimental and Cognitive Psychology, having authored 212 papers that have together received 12.1k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (49 papers), Bipolar Disorder and Treatment (39 papers), Schizophrenia research and treatment (23 papers), Treatment of Major Depression (21 papers), Electroconvulsive Therapy Studies (18 papers), Meningioma and schwannoma management (14 papers), Epigenetics and DNA Methylation (13 papers) and Cancer-related Molecular Pathways (12 papers). The work is most often cited by research in Psychiatry and Mental health (5.6k citations), Biological Psychiatry (648 citations), Genetics (1.5k citations), Clinical Psychology (2.3k citations) and Speech and Hearing (589 citations). David A. Solomon has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Martin B. Keller, Andrew C. Leon, Jean Endicott, Pamela J. Schettler, Lewis L. Judd, Hagop S. Akiskal, Jack D. Maser, William Coryell, John A. Rice and Gabor I. Keitner. Their work appears in journals such as Neuro-Oncology, CHEST Journal, American Journal of Psychiatry, The Journal of Clinical Psychiatry and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact